Hepatocellular Cancer Terminated Phase 2 Trials for Capecitabine (DB01101)

Also known as: Cancer, Hepatocellular

IndicationStatusPhase
DBCOND0037277 (Hepatocellular Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03026803A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular CancerTreatment